RNV
RENERVE LIMITED
$0.0730
▼ -1.35%
Market cap
$10M
Turnover
$7,243
Last price
$0.0730
Day change
-1.35%
Announcements
16
Range, past year
Open 0.140 · Low 0.068 · Now 0.073 · High 0.220
Open RNV in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
RNV momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
32/100
Wyckoff phase
Accumulation6d
Trend stage
Neutral
1 Day
-1.4%
1 Week
+1.4%
1 Month
-5.2%
1 Year
-39.2%
RSI
48
Avg daily range
4.3%
RENERVE LIMITED scores 32 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- Thin liquidity
- Risk rating: High
- Composite downside risk elevated
RNV announcements
Recent price-sensitive releases.
- 2026-09-21 ReNerve completes first cases in Hong Kong and Malaysia Progress Report
- 2026-09-07 ReNerve and RMIT awarded $499k grant Progress Report
- 2026-08-28 ReNerve - Appendix 4E Preliminary Final Report
- 2026-08-19 Quarterly Investor Presentation Company Presentation
- 2026-08-10 ReNerve Secures Marketing Approval in India Progress Report
- 2026-08-06 ReNerve Secures Marketing Approval in the Philippines Progress Report
- 2026-07-29 Q4 FY26 Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
More Health Care stocks
Most traded in the same sector.